RPTUAS (Revamped Pharmaceutical Technology Upgradation Assistance Scheme) is a government scheme aimed at to facilitate existing Pharma units to upgrade to revised Schedule M and WHO GMP Standards.

Key Features of RPTUAS Scheme:

Financial Assistance: Companies can claim reimbursement for the costs associated with testing of finished products, raw materials, packaging material, and other associated testing processes.  
 

Eligible Costs incurred on the following items:

1. Utilities (HVAC, Water, Steam)
2. Clean Room Facility
3. Testing Lab, Stability Chamber
4. Effluent treatment/Waste Management
5. Production Equipment
6. Consultation/Certification Expenses
7. Any other item with the recommendation of the Technical Committee
 

Reimbursement Cap

average turnover criterion for the last three years will be eligible for incentive subject to a maximum of Rs. 2.00 crore as under:-

• Turnover from Rs. 1.00 crore to less than Rs. 50.00 crore:- 20% of investment under eligible activities;
• Turnover from Rs. 50.00 crore to less than Rs. 250.00 crore:- 15% of investment under eligible activities;
• Turnover from Rs. 250.00 crore to less than Rs. 500.00 crore:- 10% of investment under eligible activities;

Eligibility criteria:

- Manufacturing License under the Drugs and Cosmetics Act, 1940, and relevant regulations.

- Type of Products: Only pharmaceutical products (finished dosage forms, active pharmaceutical ingredients, or raw materials) are eligible under this scheme.